La Jolla Institute for Immunology, San Diego, Calif.
University Hospital Southampton, Southampton, United Kingdom; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
J Allergy Clin Immunol. 2023 Nov;152(5):1196-1209. doi: 10.1016/j.jaci.2023.07.020. Epub 2023 Aug 19.
Cow milk (CM) allergy is the most prevalent food allergy in young children in the United States and Great Britain. Current diagnostic tests are either unreliable (IgE test and skin prick test) or resource-intensive with risks (food challenges).
We sought to determine whether allergen-specific T cells in CM-allergic (CMA) patients have a distinct quality and/or quantity that could potentially be used as a diagnostic marker.
Using PBMCs from 147 food-allergic pediatric subjects, we mapped T-cell responses to a set of reactive epitopes in CM that we compiled in a peptide pool. This pool induced cytokine responses in in vitro cultured cells distinguishing subjects with CMA from subjects without CMA. We further used the pool to isolate and characterize antigen-specific CD4 memory T cells using flow cytometry and single-cell RNA/TCR sequencing assays.
We detected significant changes in the transcriptional program and clonality of CM antigen-specific (CM+) T cells elicited by the pool in subjects with CMA versus subjects without CMA ex vivo. CM+ T cells from subjects with CMA had increased percentages of FOXP3 cells over FOXP3 cells. FOXP3 cells are often equated with regulatory T cells that have suppressive activity, but CM+ FOXP3 cells from subjects with CMA showed significant expression of interferon-responsive genes and dysregulated chemokine receptor expression compared with subjects without CMA, suggesting that these are not conventional regulatory T cells. The CM+ FOXP3 cells were also more clonally expanded than the FOXP3 population. We were further able to use surface markers (CD25, CD127, and CCR7) in combination with our peptide pool stimulation to quantify these CM+ FOXP3 cells by a simple flow-cytometry assay. We show increased percentages of CM+ CD127CD25 cells from subjects with CMA in an independent cohort, which could be used for diagnostic purposes. Looking specifically for T2 cells normally associated with allergic diseases, we found a small population of clonally expanded CM+ cells that were significantly increased in subjects with CMA and that had high expression of T2 cytokines and pathogenic T2/T follicular helper markers.
Overall, these findings suggest that there are several differences in the phenotypes of CM+ T cells with CM allergy and that the increase in CM+ FOXP3 cells is a potential diagnostic marker of an allergic state. Such markers have promising applications in monitoring natural disease outgrowth and/or the efficacy of immunotherapy that will need to be validated in future studies.
牛奶过敏是美国和英国幼儿中最常见的食物过敏。目前的诊断测试要么不可靠(IgE 测试和皮肤点刺测试),要么资源密集且存在风险(食物挑战)。
我们试图确定牛奶过敏(CMA)患者中的过敏原特异性 T 细胞是否具有独特的质量和/或数量,这些特性可能可用作诊断标志物。
使用来自 147 名食物过敏儿科患者的 PBMC,我们对一组在 CM 中反应的 T 细胞进行了映射,这些反应是我们在肽池中编译的。该池在体外培养的细胞中诱导细胞因子反应,将 CMA 患者与非 CMA 患者区分开来。我们进一步使用该池通过流式细胞术和单细胞 RNA/TCR 测序分析来分离和表征抗原特异性 CD4 记忆 T 细胞。
我们检测到 CMA 患者与非 CMA 患者体外 CM 抗原特异性(CM+)T 细胞对池的转录程序和克隆性发生了显著变化。与非 CMA 患者相比,CMA 患者的 CM+T 细胞中 FOXP3 细胞的百分比增加。FOXP3 细胞通常等同于具有抑制活性的调节性 T 细胞,但与非 CMA 患者相比,CMA 患者的 CM+FOXP3 细胞表现出干扰素反应基因的显著表达和趋化因子受体表达失调,表明这些细胞不是常规的调节性 T 细胞。CM+FOXP3 细胞的克隆扩增也比 FOXP3 群体更多。我们还能够使用表面标记物(CD25、CD127 和 CCR7)结合我们的肽池刺激,通过简单的流式细胞术检测来定量这些 CM+FOXP3 细胞。我们显示出 CMA 患者的 CM+CD127CD25 细胞百分比增加,这在另一组独立队列中也可以用于诊断目的。专门寻找通常与过敏疾病相关的 T2 细胞,我们发现一小部分克隆扩增的 CM+细胞在 CMA 患者中显著增加,并且具有高表达的 T2 细胞因子和致病性 T2/T 滤泡辅助标志物。
总的来说,这些发现表明 CM 过敏患者的 CM+T 细胞表型存在多种差异,CM+FOXP3 细胞的增加是过敏状态的潜在诊断标志物。这些标志物在监测自然疾病发展和/或免疫疗法的疗效方面具有广阔的应用前景,未来需要在研究中进行验证。